| Name | Title | Contact Details |
|---|---|---|
Matt Berkle |
Head of U.S. Compliance | Profile |
Caliva, San Jose`s premier medical marijuana dispensary and cultivation facility opened in July of 2015 and in September of 2016 was ranked #1 dispensary in the nation by Business Insider. Our facility is one of the most advanced pharmaceutical-grade cannabis cultivating, manufacturing, and dispensing facilities in the country and a model for energy efficiency, safe access, and compliance. We started Caliva because we believe strongly in the medicinal and wellness applications of cannabis. From inception, our goal has been to establish a regulated, safe and consistent source of cannabis for our patients. We believe strongly in a medical cannabis industry that is well-regulated, highly professional, and rigorously secure. Each one of our strains is selected for its genetics and superior medicinal effects and then tested to ensure that the quality we offer is only the best. Our attitude is easy, but our focus is to provide the highest level of service in the industry; our educated and passionate team provide a comfortable, safe and easy buying experience.
Since 2005, Ekso Bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company`s first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable. Ekso Bionics is headquartered in Richmond, CA and is listed on the OTC QB under the symbol EKSO.
Hospice Source is a Carrollton, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
The MEDICREA Group specializes in the design, manufacture, and distribution of innovative proprietary technologies devoted exclusively to spinal surgery. Operating in a $10 billion market, MEDICREA is a small to medium-sized business with 140 employees, including 40 at its MEDICREA USA Corp. subsidiary based in New York City. The Company enjoys an excellent and ever-improving reputation, and develops unique scientific partnerships with some of the most visionary and creative spine surgeons in France, the UK, and the USA. The products developed and patented by MEDICREA provide neurosurgeons and orthopedic surgeons specializing in the spine with new and less-invasive surgical solutions that are faster and easier to implement than traditional techniques. MEDICREA has also become a pioneer and global leader in the manufacturing of customized implants for personalized spinal surgery with the development of a comprehensive process incorporating the software analysis of each patient, the pre-surgical planning of the surgical strategy, and the production of customized spinal osteosynthesis rods (UNiD™ rod) and lumbar interbody osteosynthesis cages (UNiD™ ALIF cage) that are made to measure by a 3D printer. The Group`s headquarters are based near Lyon, France. It also has an implant and surgical instrument manufacturing facility located in La Rochelle, France, as well as four distribution subsidiaries in the USA, the UK, France and Germany.
Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital health to drive transformation across the surgical landscape. Uniquely aligned and resourced to advance the standard of care, the company is building technologies physicians and other health providers will look to for what is truly possible for their patients. Surgalign is focused on developing solutions that predictably deliver superior clinical and economic outcomes. Surgalign markets products throughout the United States and in approximately 50 countries worldwide through an expanding network of top independent distributors. Surgalign is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Warsaw and Poznan, Poland and Wurmlingen, Germany.